{"address1": "Bellevue Centre", "address2": "Suite 300 235 -15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "phone": "604-921-1810", "fax": "604-921-1898", "website": "https://briacell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams M.D.", "age": 69, "title": "CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 734419, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A.", "age": 51, "title": "CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 443000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miguel A. Lopez-Lago Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 357745, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Giuseppe  Del Priore M.D., M.P.H., MPH", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 540329, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Charles Louis Wiseman FACP, M.D.", "age": 77, "title": "Founder, Principal Research Advisor & Member of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 241138, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0887, "open": 0.0851, "dayLow": 0.102, "dayHigh": 0.102, "regularMarketPreviousClose": 0.0887, "regularMarketOpen": 0.0851, "regularMarketDayLow": 0.102, "regularMarketDayHigh": 0.102, "beta": 1.857, "volume": 22, "regularMarketVolume": 22, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.102, "fiftyTwoWeekHigh": 0.102, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 3199281, "bookValue": 1.223, "priceToBook": 0.083401464, "netIncomeToCommon": -11592001, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.102, "recommendationKey": "none", "totalCash": 5013654, "totalCashPerShare": 1.352, "ebitda": -27190304, "totalDebt": 0, "quickRatio": 1.369, "currentRatio": 1.369, "returnOnAssets": -1.58141, "freeCashflow": -11424954, "operatingCashflow": -21994862, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCTXW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 14.994365, "regularMarketPrice": 0.102, "marketState": "PRE", "shortName": "BriaCell Therapeutics Corp.", "longName": "BriaCell Therapeutics Corp.", "corporateActions": [], "regularMarketTime": 1743451200, "exchange": "NCM", "messageBoardId": "finmb_262266102", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.013300002, "regularMarketDayRange": "0.102 - 0.102", "fullExchangeName": "NasdaqCM", "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.102 - 0.102", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-24", "cryptoTradeable": false, "hasPrePostMarketData": true, "displayName": "BriaCell Therapeutics", "trailingPegRatio": null}